Company
Headquarters: Taipei, Taiwan
TW$1.07 Billion
TWD as of Jan. 1, 2024
US$34.9 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Lukas Biomedical Inc. engages in the research and the development of immunotherapy for cancer treatment. It is also involved in the rental of medical equipment. The company was founded in 2014 and is headquartered in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Lukas Biomedical, Inc. has the following listings and related stock indices.
Stock: TWSE: 6814 wb_incandescent